Press Releases

Novo Nordisk announced that the US FDA has approved the NDA for Xultophy® 100/3.6.Xultophy® 100/3.6 is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin...

GSK  announced it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication for FluLaval® Quadrivalent (Influenza Vaccine) to include use in children 6 months and older. ...

UBM India, India's leading exhibition organizer, launched the India Pharma Week, a bouquet of over 10 trend-setting activities across the city of Mumbai, to mark the special 10th anniversary of CPhI & P-MEC India 2016, its flagship event and...

Egalet Corporation , a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,announced the issuance of a United States patent covering OXAYDO® (oxycodone HCI, USP) tablets for oral use only–CII....

Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare,announced the launch of the Comprehensive® Vault Reconstruction System (VRS),the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss...

On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the world’s largest and most comprehensive processing and packaging show in 2016. Show owner and producer PMMI, The Association...

AstraZeneca announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global rights to MEDI2070. MEDI2070 is an IL-23 monoclonal antibody currently in a Phase...